These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8854045)

  • 41. Synthesis and pharmacological study of 4,4a,5,6-tetrahydro-4a-substituted-benzo(h)cinnolin-3(2H)ones.
    Barlocco D; Pinna GA; Carboni L; Cipolla P
    Farmaco; 1989 Oct; 44(10):967-74. PubMed ID: 2619862
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Novel synthetic approach to N-aryl-4-(3-pyridyl)thiazol-2-amine and analogues using HMCM-41 as catalyst, and their biological evaluation as human platelet aggregation inhibitors.
    Bhoga U
    Eur J Med Chem; 2007 Aug; 42(8):1144-50. PubMed ID: 17350143
    [TBL] [Abstract][Full Text] [Related]  

  • 43. New platelet aggregation inhibitors based on pyridazinone moiety.
    Costas T; Costas-Lago MC; Vila N; Besada P; Cano E; Terán C
    Eur J Med Chem; 2015 Apr; 94():113-22. PubMed ID: 25757094
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthesis and biological evaluation of substituted benzo[h]cinnolinones and 3H-benzo[6,7]cyclohepta[1,2-c]pyridazinones: higher homologues of the antihypertensive and antithrombotic 5H-indeno[1,2-c]pyridazinones.
    Cignarella G; Barlocco D; Pinna GA; Loriga M; Curzu MM; Tofanetti O; Germini M; Cazzulani P; Cavalletti E
    J Med Chem; 1989 Oct; 32(10):2277-82. PubMed ID: 2795599
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Functionalized pyrazoles and pyrazolo[3,4-d]pyridazinones: Synthesis and evaluation of their phosphodiesterase 4 inhibitory activity.
    Biagini P; Biancalani C; Graziano A; Cesari N; Giovannoni MP; Cilibrizzi A; Dal Piaz V; Vergelli C; Crocetti L; Delcanale M; Armani E; Rizzi A; Puccini P; Gallo PM; Spinabelli D; Caruso P
    Bioorg Med Chem; 2010 May; 18(10):3506-17. PubMed ID: 20413313
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 5-Acyl-6-aryl-4-nitro-3(2H)pyridazinones and related 4-amino compounds: synthesis and pharmacological evaluation.
    Dal Piaz V; Ciciani G; Turco G; Giovannoni MP; Miceli M; Pirisino R; Perretti M
    J Pharm Sci; 1991 Apr; 80(4):341-8. PubMed ID: 1865334
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The evaluation and structure-activity relationships of 2-benzoylaminobenzoic esters and their analogues as anti-inflammatory and anti-platelet aggregation agents.
    Hsieh PW; Hwang TL; Wu CC; Chiang SZ; Wu CI; Wu YC
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1812-7. PubMed ID: 17197180
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Imidazo[1,2-b]pyridazines, novel nucleus with potent and broad spectrum activity against human picornaviruses: design, synthesis, and biological evaluation.
    Hamdouchi C; Sanchez-Martinez C; Gruber J; Del Prado M; Lopez J; Rubio A; Heinz BA
    J Med Chem; 2003 Sep; 46(20):4333-41. PubMed ID: 13678411
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase.
    Chlopicki S; Olszanecki R; Marcinkiewicz E; Lomnicka M; Motterlini R
    Cardiovasc Res; 2006 Jul; 71(2):393-401. PubMed ID: 16713591
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synthesis of N1-substituted benzamidines. Effects on blood coagulation, platelet aggregation and antiarrhythmic activity.
    Ferroni R; Simoni D; Manfredini S; Guarneri M; Orlandini P; Barbieri M; Franzè GP; Mugelli A
    Arzneimittelforschung; 1995 Jun; 45(6):665-9. PubMed ID: 7646567
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anti-HAV activity of some newly synthesized triazolo[4,3-b]pyridazines.
    Shamroukh AH; Ali MA
    Arch Pharm (Weinheim); 2008 Apr; 341(4):223-30. PubMed ID: 18214848
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pyridazinone derivatives: design, synthesis, and in vitro vasorelaxant activity.
    Abouzid K; Abdel Hakeem M; Khalil O; Maklad Y
    Bioorg Med Chem; 2008 Jan; 16(1):382-9. PubMed ID: 17905589
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthesis and antiplatelet activity of ethyl 4-(1-benzyl-1H-indazol-3-yl)benzoate (YD-3) derivatives.
    Chen HS; Kuo SC; Teng CM; Lee FY; Wang JP; Lee YC; Kuo CW; Huang CC; Wu CC; Huang LJ
    Bioorg Med Chem; 2008 Feb; 16(3):1262-78. PubMed ID: 17988878
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis, identification and antiplatelet evaluation of 2-morpholino substituted benzoxazines.
    Pritchard KM; Al-Rawi J; Bradley C
    Eur J Med Chem; 2007 Sep; 42(9):1200-10. PubMed ID: 17336427
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Synthesis and antiaggregative activity of a new RGDF mimetic].
    Krys'ko AA; Malovichko OL; Kabanova TA; Mazepa AV
    Bioorg Khim; 2004; 30(6):594-8. PubMed ID: 15586810
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Structure-activity relationship studies on chalcone derivatives: potent inhibition of platelet aggregation.
    Ko HH; Hsieh HK; Liu CT; Lin HC; Teng CM; Lin CN
    J Pharm Pharmacol; 2004 Oct; 56(10):1333-7. PubMed ID: 15482650
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis and antifeedant activity of new oxadiazolyl 3(2H)-pyridazinones.
    Cao S; Qian X; Song G; Chai B; Jiang Z
    J Agric Food Chem; 2003 Jan; 51(1):152-5. PubMed ID: 12502400
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition of platelet aggregation by olive oil phenols via cAMP-phosphodiesterase.
    Dell'Agli M; Maschi O; Galli GV; Fagnani R; Dal Cero E; Caruso D; Bosisio E
    Br J Nutr; 2008 May; 99(5):945-51. PubMed ID: 17927845
    [TBL] [Abstract][Full Text] [Related]  

  • 59. NO-donors, part 9 : diazeniumdiolates inhibit human platelet aggregation and induce a transient vasodilatation of porcine pulmonary arteries in accordance with the NO-releasing rates.
    Abuo-Rahma Gel D; Horstmann A; Radwan MF; El-Emam A; Glusa E; Lehmann J
    Eur J Med Chem; 2005 Mar; 40(3):281-7. PubMed ID: 15725497
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis, antitubercular, antifungal and antibacterial activities of 6-substituted phenyl-2-(3'-substituted phenyl pyridazin-6'-yl)-2,3,4,5-tetrahydropyridazin-3-one.
    Islam M; Siddiqui AA; Rajesh R
    Acta Pol Pharm; 2008; 65(3):353-62. PubMed ID: 18646555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.